Group 1 - The company held its 25th meeting of the 6th Board of Directors on August 21, 2025, with all 7 directors present, and the meeting complied with relevant laws and regulations [1] - The meeting approved the 2025 semi-annual report and its summary with unanimous consent [1] - The company proposed a cash dividend distribution plan of CNY 0.50 per 10 shares (including tax) based on a total share capital of 1,672,828,214 shares as of June 30, 2025, after deducting shares in the repurchase account [1] Group 2 - The company plans to apply for a comprehensive credit facility from banks, with a total amount not exceeding CNY 2.25 billion, to meet operational liquidity needs and expand financing channels [3]

Core Viewpoint - The company Huace Testing (300012.SZ) reported a revenue of 2.96 billion yuan for the first half of 2025, reflecting a year-on-year growth of 6.05% [1] - The net profit attributable to shareholders reached 467 million yuan, marking a year-on-year increase of 7.03% [1] - The net profit after deducting non-recurring gains and losses was 439 million yuan, showing a year-on-year growth of 9.08% [1] - The basic earnings per share were 0.2793 yuan, and the company proposed a cash dividend of 0.5 yuan per 10 shares (tax included) for all shareholders [1] Financial Performance - Revenue for the first half of 2025: 2.96 billion yuan, up 6.05% year-on-year [1] - Net profit attributable to shareholders: 467 million yuan, up 7.03% year-on-year [1] - Net profit excluding non-recurring items: 439 million yuan, up 9.08% year-on-year [1] - Basic earnings per share: 0.2793 yuan [1] Dividend Policy - Proposed cash dividend: 0.5 yuan per 10 shares (tax included) [1]

2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 安徽华测检测技术 | 控 股 子 公 司 | 其他应收款 | 64,185,228. | 62,321,48 | | 资金调拨 | 非经营性往 | | --- | --- | --- | --- | --- | --- | --- | --- | | 有限公司 | 控制的法人 | | 66 | 3.07 | 1,863,745.59 | 款 | 来 | | 海南省华测技术服 务有限公司 | 控股子公司 | 其他应收款 | 465,313.04 | 30,000.00 | 435,313.04 | 资金调拨 款 | 非经营性往 来 | | 武汉市华信理化检 | 控 股 子 公 司 | 其他应收款 | 22,808,997. | 22,772,42 | 36,573.62 | 资金调拨 | 非经营性往 | | 测技术有限公司 | 控制的法人 | | 48 | 3.86 | | 款 | 来 | | 厦门市华测检测技 | 控 股 子 公 司 | 其他应收款 | 45,894,948. | 45,867,36 | 27,588.23 | 资金调拨 | ...

| 序号 | 银行名称 | 授信额度 （亿元） | 授信期限 | | --- | --- | --- | --- | | 1 | 国家开发银行 | 2.00 | 一年 | | 2 | 招商银行股份有限公司 | 3.00 | 两年 | | 3 | 广发银行股份有限公司 | 3.00 | 一年 | | 4 | 浦发银行股份有限公司 | 3.00 | 一年 | | 5 | 农业银行股份有限公司 | 2.00 | 一年 | | 6 | 汇丰银行（中国）有限公司 | 1.20 | 一年 | | 7 | 中国银行股份有限公司 | 1.50 | 一年 | | 8 | 华润银行股份有限公司 | 1.00 | 一年 | | 9 | 工商银行股份有限公司 | 1.00 | 一年 | | 10 | 交通银行股份有限公司 | 1.00 | 两年 | | 11 | 建设银行股份有限公司 | 3.00 | 一年 | | 12 | 中国民生银行股份有限公司 | 0.20 | 一年 | | 13 | 宁波银行股份有限公司 （固定资产贷款额度） | 0.40 | 五年 | | 14 | 宁波银行股份有限公司 | 0.20 | 一年 | | | ...

华测检测认证集团股份有限公司 2025 年半年度财务报告 华测检测认证集团股份有限公司 2025 年半年度财务报告 2025 年 8 月 22 日 1 华测检测认证集团股份有限公司 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 编制单位：华测检测认证集团股份有限公司 | | | 单位：元 | | --- | --- | --- | | 项目 | 期末余额 | 期初余额 | | 流动资产： | | | | 货币资金 | 850,423,186.98 | 882,727,579.22 | | 结算备付金 | | | | 拆出资金 | | | | 交易性金融资产 | 143,613,981.74 | 443,026,438.36 | | 衍生金融资产 | | | | 应收票据 | 54,745,986.12 | 24,062,986.59 | | 应收账款 | 2,155,837,125.54 | 1,980,208,076.51 | | 应收款项融资 | | | | 预付款项 | 44,899 ...

华测检测认证集团股份有限公司（以下简称"公司"）第六届监事会第十八 次会议于 2025 年 8 月 11 日发出会议通知，2025 年 8 月 21 日以现场结合通讯方式 召开。本次会议应参加监事 3 人，实际参加监事 3 人，分别为：陈炜明、杜学志、 张渝民。本次会议召开符合《公司法》和《公司章程》的有关规定。会议由公司 监事会主席陈炜明先生主持，经与会监事认真审议，形成如下决议： 一、会议以 3 票同意、0 票反对、0 票弃权，审议通过《2025 年半年度报告全文 及摘要》 监事会认为，公司董事会编制和审核的《2025 年半年度报告全文及其摘要》 的程序符合法律、行政法规、中国证监会和深交所的规定，报告的内容真实、准 确、完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大 遗漏。 公司《2025 年半年度报告全文及摘要》具体内容详见巨潮资讯网的相关公告。 证券代码：300012 证券简称：华测检测 公告编号：2025-039 华测检测认证集团股份有限公司 第六届监事会第十八次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 具体 ...

证券代码：300012 证券简称：华测检测 公告编号：2025-036 华测检测认证集团股份有限公司 第六届董事会第二十五次会议决议公告 公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）第六届董事会第二十 五次会议，于 2025 年 8 月 11 日发出会议通知，2025 年 8 月 21 日以现场结合通讯 方式召开。本次会议应参与董事 7 名，实际参与董事 7 名，分别为：万峰、申屠 献忠、钱峰、戚观成、曾繁礼、程海晋、刘志权。会议由董事长万峰主持，董事 会会议的举行和召开符合国家有关法律、法规及《公司章程》的规定。经充分讨 论和审议，会议形成决议如下： 一、会议以 7 票同意、0 票反对、0 票弃权，审议通过了《2025 年半年度报告全 文及摘要》 综合考虑公司经营情况及整体财务状况，为回报投资者并树立股东对公司的 长期投资理念，根据《公司法》《上市公司监管指引第 3 号——上市公司现金分 红》《公司章程》等相关规定，经公司股东大会授权，公司 2025 年半年度利润分 配方案为：拟以未来实施分配方案时股权登记日 ...

证券代码：300012 证券简称：华测检测 公告编号：2025-038 华测检测认证集团股份有限公司 关于2025年半年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）于2025年8月21日召 开第六届董事会第二十五次会议，审议通过了《2025年半年度利润分配预案》， 本议案无需提交股东大会审议。现将该预案的基本情况公告如下： 一、2025 年半年度利润分配预案基本情况 公 司 2025 年 半 年 度 合 并 报 表 实 现 归 属 于 母 公 司 所 有 者 净 利 润 467,280,687.93 元，加上年初未分配利润 4,549,382,906.01 元，减去报告期已 分配的 2024 年度现金股利 167,282,821.40 元，减去计提的法定盈余公积金 19,387,815.95 元，可供股东分配的利润为 4,829,992,956.59 元；2025 年半年 度 母 公 司 实 现 净 利 润 193,878,159.53 元 ， 加 上 年 初 未 分 配 利 润 2,6 ...

Core Viewpoint - The company Huace Testing (300012.SZ) reported a revenue of 2.959 billion yuan for the first half of 2025, reflecting a year-on-year growth of 6.05% and a net profit of 467 million yuan, which is a 7.03% increase compared to the previous year [1] Financial Performance - Revenue for the first half of 2025 reached 2.959 billion yuan, marking a 6.05% increase year-on-year [1] - Net profit for the same period was 467 million yuan, showing a year-on-year growth of 7.03% [1] Dividend Announcement - The company plans to distribute a cash dividend of 0.5 yuan per 10 shares (including tax) [1]

Financial Performance - The company's revenue for the reporting period reached ¥2,959,950,536.01, representing a 6.05% increase compared to ¥2,791,125,806.80 in the same period last year[28]. - Net profit attributable to shareholders was ¥467,280,687.93, up 7.03% from ¥436,594,715.48 year-on-year[28]. - The net cash flow from operating activities surged by 686.93% to ¥174,803,678.10, compared to ¥22,213,325.50 in the previous year[28]. - The company's EBITDA for the reporting period was ¥795,716,594.12, reflecting a 4.39% increase from ¥762,242,867.96 in the previous year[28]. - The basic earnings per share for the reporting period was ¥0.2793, an increase of 7.18% from ¥0.2606 in the same period last year[28]. - The company achieved a revenue of 2.96 billion CNY in the reporting period, representing a year-on-year growth of 6.05%[59]. - The net profit attributable to shareholders reached 467 million CNY, an increase of 7.03% year-on-year, while the net profit excluding non-recurring items was 439 million CNY, up 9.08%[59]. Investment and R&D - The company invests 8% to 10% of its revenue annually into innovation and R&D, focusing on new project development and incubation[57]. - The company invested 5.29 billion RMB in R&D in 2024, an increase of 11.99% year-on-year, accounting for 8.70% of revenue[114]. - The company has established a postdoctoral innovation practice base, attracting 10 postdoctoral researchers to enhance its technological innovation capabilities[113]. - The company is committed to enhancing its technical capabilities and service levels through ongoing investment in technology research and development[80]. Quality Control and Compliance - The company emphasizes maintaining credibility and brand integrity, implementing a comprehensive quality control system to ensure the accuracy of testing reports[5]. - The company has established a quality supervision management system in compliance with international standards such as ISO/IEC17025 and ISO/IEC17020[5]. - The company has established a comprehensive quality management system based on ISO/IEC17025 and ISO/IEC17020, ensuring international credibility of its testing reports[45]. - The company has implemented a quality risk management responsibility system in key sectors, significantly enhancing overall quality awareness and accelerating problem response[48]. Market Expansion and Strategic Initiatives - The company is actively monitoring policy risks in the testing industry and has established a dedicated department to respond to potential regulatory changes[9]. - The company aims to enhance the operational efficiency of newly established laboratories to gradually release capacity and achieve steady revenue growth[12]. - The company is positioned to benefit from the increasing demand for quality assurance in traditional and high-end industries as they transition and expand internationally[43]. - The company plans to continue its market expansion strategy, focusing on increasing shareholder value through strategic investments and acquisitions[169]. Acquisitions and Mergers - The company has adopted a cautious approach to mergers and acquisitions, conducting thorough due diligence and strategic analysis before proceeding[10]. - The company completed the acquisition of ALS Group's subsidiary in China, enhancing its capabilities in geochemical testing and expanding into upstream raw material analysis[74]. - The acquisition of Openview will enrich the company's international qualifications in social responsibility audits, particularly in the ESG sector, with completion expected in Q3 2025[76]. - The company signed an agreement to acquire Safety SA, a leading testing, inspection, certification, and training service provider in South Africa, expected to enhance its service capabilities in Africa by Q4 2025[77]. Employee Engagement and Stock Ownership - The company has implemented three phases of share repurchase plans, totaling 3 million shares for 63.51 million RMB in the first phase, 5 million shares for 71.50 million RMB in the second phase, and 2 million shares for 22.05 million RMB in the third phase[112]. - The company has been actively revising its employee stock ownership plans to enhance employee engagement and retention[124]. - The first employee stock ownership plan was approved in June 2017, with subsequent adjustments made in 2019 and 2021[122]. - The company plans to potentially launch a new employee stock ownership plan within the next 12 months[127]. Operational Efficiency - The company is focusing on improving internal capital expenditure management and conducting detailed investment return analyses[12]. - The company has implemented a "123 strategy" to enhance service quality and drive innovation, focusing on customer orientation and operational excellence[59]. - The company has launched a talent development initiative, "Climbing to Win," aimed at supporting new managers in their transition, with significant growth in customized training programs[82]. - The implementation of lean management projects has progressed, with multiple laboratory improvements completed across various locations, enhancing operational efficiency[81]. Industry Trends and Challenges - The inspection and testing industry achieved a revenue of CNY 487.6 billion in 2024, representing a year-on-year growth of 4.41%, a slowdown from 9.2% in 2023[41]. - The number of certified inspection and testing institutions in China decreased by 1.44% in 2024, indicating a shift from rapid expansion to intensified competition based on service quality and brand influence[41]. - The testing and inspection industry is experiencing increasing concentration, with larger and stronger institutions gaining competitive advantages, leading to accelerated market consolidation[44]. Financial Position and Assets - The company’s total assets at the end of the reporting period were ¥9,449,828,564.27, a slight decrease of 0.03% from ¥9,452,604,079.86 at the end of the previous year[28]. - The net assets attributable to shareholders increased by 4.39% to ¥7,216,959,327.94 from ¥6,913,388,893.02[28]. - The company reported a net increase in cash and cash equivalents of ¥38,568,775.95, a 93.29% improvement from a net decrease of ¥574,813,597.85 in the prior year[83]. - The company’s total liabilities included short-term borrowings of ¥2,002,016.65 at the beginning of the period, which was not present at the end of the period[182].